These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29218901)

  • 21. Is computer-assisted, long-term warfarin therapy safe and efficacious for patients with nonrheumatic atrial fibrillation?
    Perez-Gomez F
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):82-3. PubMed ID: 16265377
    [No Abstract]   [Full Text] [Related]  

  • 22. A patient decision aid to support shared decision-making on anti-thrombotic treatment of patients with atrial fibrillation: randomised controlled trial.
    Thomson RG; Eccles MP; Steen IN; Greenaway J; Stobbart L; Murtagh MJ; May CR
    Qual Saf Health Care; 2007 Jun; 16(3):216-23. PubMed ID: 17545350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review and inventory of supplement effects on warfarin and other anticoagulants.
    Wittkowsky AK
    Thromb Res; 2005; 117(1-2):81-6; discussion 113-5. PubMed ID: 15921725
    [No Abstract]   [Full Text] [Related]  

  • 24. Risks and Benefits of Warfarin Versus New Oral Anticoagulant Drugs.
    Jacek G
    Home Healthc Now; 2017 Apr; 35(4):231-232. PubMed ID: 28353517
    [No Abstract]   [Full Text] [Related]  

  • 25. Genetic determinants of warfarin maintenance dose and time in therapeutic treatment range: a RE-LY genomics substudy.
    Eriksson N; Wallentin L; Berglund L; Axelsson T; Connolly S; Eikelboom J; Ezekowitz M; Oldgren J; Paré G; Reilly P; Siegbahn A; Syvanen AC; Wadelius C; Yusuf S; Wadelius M
    Pharmacogenomics; 2016 Aug; 17(13):1425-39. PubMed ID: 27488176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United kingdom.
    Guest JF; Watson HG; Limaye S
    Clin Ther; 2010 Dec; 32(14):2478-93. PubMed ID: 21353116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose warfarin prophylaxis for catheter-associated thrombosis in cancer patients. Can it be safely associated with 5-Fluorouracil-based chemotherapy?
    Magagnoli M; Castagna L; Masci G; Santoro A
    Oncologist; 2004; 9(5):594-5; author reply 596. PubMed ID: 15477645
    [No Abstract]   [Full Text] [Related]  

  • 28. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical outcomes of a pharmacist-managed anticoagulation service for breast cancer patients.
    Jones KL; Barnett C; Gauthier M; Boster B; Espirito JL; Michaud LB
    J Oncol Pharm Pract; 2012 Mar; 18(1):122-7. PubMed ID: 21364079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are Evidence Standards Different for Genomic- vs. Clinical-Based Precision Medicine? A Quantitative Analysis of Individualized Warfarin Therapy.
    Dhanda DS; Guzauskas GF; Carlson JJ; Basu A; Veenstra DL
    Clin Pharmacol Ther; 2017 Nov; 102(5):805-814. PubMed ID: 28187492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of a Guideline for the Management of Antimicrobial/Warfarin Interactions in the Inpatient Setting and Across Transition of Care.
    Ha NB; Yang K; Hanigan S; Kurtz B; Dorsch MP; Mak H; Nagel J
    Ann Pharmacother; 2016 Sep; 50(9):734-40. PubMed ID: 27317014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetaminophen and other risk factors for excessive warfarin anticoagulation.
    Hylek EM; Heiman H; Skates SJ; Sheehan MA; Singer DE
    JAMA; 1998 Mar; 279(9):657-62. PubMed ID: 9496982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Bayesian approach to evaluating net clinical benefit allowed for parameter uncertainty.
    Sutton AJ; Cooper NJ; Abrams KR; Lambert PC; Jones DR
    J Clin Epidemiol; 2005 Jan; 58(1):26-40. PubMed ID: 15649668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation.
    Eckman MH; Rosand J; Greenberg SM; Gage BF
    Ann Intern Med; 2009 Jan; 150(2):73-83. PubMed ID: 19153410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Warfarin therapy: evolving strategies in anticoagulation.
    Horton JD; Bushwick BM
    Am Fam Physician; 1999 Feb; 59(3):635-46. PubMed ID: 10029789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Warfarin: an old drug but still interesting.
    Johnson JA
    Pharmacotherapy; 2008 Sep; 28(9):1081-3. PubMed ID: 18752378
    [No Abstract]   [Full Text] [Related]  

  • 37. Warfarin therapy for elderly persons with atrial fibrillation.
    Ackermann RJ
    Am Fam Physician; 1998 Jul; 58(1):45-6, 48-9. PubMed ID: 9672429
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of a contemporary bleeding risk model for elderly warfarin recipients.
    Shireman TI; Mahnken JD; Howard PA; Kresowik TF; Hou Q; Ellerbeck EF
    Chest; 2006 Nov; 130(5):1390-6. PubMed ID: 17099015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Warfarin. Proper use of this common anticoagulant is important.
    Mayo Clin Health Lett; 2000 May; 18(5):6. PubMed ID: 10791354
    [No Abstract]   [Full Text] [Related]  

  • 40. SAMe-TT
    Kataruka A; Kong X; Haymart B; Kline-Rogers E; Almany S; Kozlowski J; Krol GD; Kaatz S; McNamara MW; Froehlich JB; Barnes GD
    Vasc Med; 2017 Jun; 22(3):197-203. PubMed ID: 28145152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.